Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).
about
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing populationLeptin and Lipid Profile in Overweight Patient with Type 1 Diabetes.Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetesLong-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions.Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus.Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes.Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus.Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes.Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosisHbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patientsAssociation of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV DatabaseOverweight and Obesity Based on Four Reference Systems in 18,382 Paediatric Patients with Type 1 Diabetes from Germany and Austria.Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals InitiativePredicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study.Dyslipidemia in youth with diabetes: to treat or not to treat?Teaching children with diabetes about adequate dietary choices.Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study.Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetesPrevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetesMicrovascular complications in adolescents with type 1 diabetes mellitus.Insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus.Exercise training improves cardiac autonomic nervous system activity in type 1 diabetic children.Treatment of dyslipidaemia in childhood.Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?Macrovascular angiopathy in children and adolescents with type 1 diabetes.Cardiovascular disease risk in young people with type 1 diabetes.Risks and benefits of statin use in young people with type 1 diabetes.Review of cardiometabolic risk factors in a cohort of paediatric type 1 diabetes mellitus patients.Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database.Cerebrovascular complications of diabetes: focus on cognitive dysfunctionPrevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes in Austria.Lipid profile and correlation to cardiac risk factors and cardiovascular function in type 1 adolescent diabetics from a developing country.Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study.Pulse pressure in children and adolescents with type 1 diabetes mellitus in Germany and Austria.Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.
P2860
Q26777077-29E68691-EC58-4138-99FD-B8872981B8C1Q33646057-0BD5FFAE-ADA9-4BC6-8624-A5F337BA2E7AQ33664505-2BA55D33-4868-4780-AFEE-A43E66AF1876Q33804600-D2310EF3-2D6C-4D82-84CA-F9B69DCEA28AQ34204915-0382986E-6FE4-4FCA-992C-A78CFF1CC425Q34219439-DD2734E0-4135-48BF-A667-6074F707CEC2Q34440576-87B50B91-6608-45B8-B7CF-F6EE8304C68CQ34620412-CA753369-912A-4864-B8E9-554344AC9E4CQ34718616-E97217AA-AABD-493C-84C0-9868C26579F0Q34962507-6BFE1F1C-DFC4-4D32-B6CD-AA2EEB3632C9Q35046826-6564EB0C-BE90-4EF3-ABC6-F9DA244B031EQ35060841-6D10A9AC-0C3F-4C8B-A097-08A006223C86Q35086814-053C9ABB-2F34-4AB3-ABD0-F86342940DD2Q35114974-9830783F-C144-4DC8-8E47-6283889A87A3Q35667553-A4149565-84E0-4967-8365-E140AC88D353Q35692338-DE277725-2081-456F-AC6A-AA9D062ACB7EQ35739669-D6C3EE89-69CF-4A38-AAFF-E685088D551DQ36151302-5B56266A-FD76-4D90-BC57-5AE1DF69F5A8Q36675872-315F74D4-D13F-45DB-8CFD-6AD2048CDDA7Q36977819-5A5C5786-2961-423C-9559-BC438EF5C202Q37079313-871F543B-6C85-456A-92C6-3BB9B320729CQ37109434-B73F6AD6-0F12-48EA-BA25-AA8484B06A13Q37113661-AF915BB2-B2A6-46F0-8409-32D33B1D288BQ37139501-4B43BB3B-FC6C-41DA-B462-727B278F2970Q37271508-C797CABB-7295-4ECE-A57D-6150EE2507DEQ37358869-74932A2A-9526-43D8-AD02-5760A3C2C80FQ37589449-37F8248A-26D0-447C-9D35-0151743A44B7Q37704394-448C3707-EF61-4458-9F32-BA761D003B18Q37807503-9A0466EC-2700-4BEF-8299-E34CA8EF628DQ37857087-D129B4BD-D7A3-4F1B-88B1-93744D66A836Q38005031-36DDBCD7-0E0F-4315-8A14-27BBBB265CADQ38209424-779827CF-8055-456F-825A-45791CA9E1F6Q38809413-BCD93B94-C2CC-45B9-8028-79A336642C4EQ38931596-4B15ED7D-B203-4196-B132-00E887C5EB62Q38955965-B2DD4959-3736-4587-964F-C5FA33EA7CB8Q39640211-B5A6E6EB-A47A-4BC1-A94E-DBBBA2375D86Q40008904-95403A20-EB68-4A7A-A360-D9C769E03B59Q40362789-DEFC9F6C-841F-4F07-B82B-833B178F3A6DQ41368984-3B1696F9-6A6B-499E-AD60-3B60C4B7BA99Q44418300-9FB58358-1629-4DFE-89FB-3AA113562612
P2860
Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Spectrum and prevalence of ath ...... ality management system (DPV).
@ast
Spectrum and prevalence of ath ...... ality management system (DPV).
@en
type
label
Spectrum and prevalence of ath ...... ality management system (DPV).
@ast
Spectrum and prevalence of ath ...... ality management system (DPV).
@en
prefLabel
Spectrum and prevalence of ath ...... ality management system (DPV).
@ast
Spectrum and prevalence of ath ...... ality management system (DPV).
@en
P2093
P921
P1433
P1476
Spectrum and prevalence of ath ...... ality management system (DPV).
@en
P2093
DPV Initiative of the German Working Group for Pediatric Diabetology
Dagobert Wiemann
Jürgen Doerfer
Jürgen Grulich-Henn
K Otfried Schwab
Olga Kordonouri
Peter Beyer
Reinhard W Holl
Wolfgang Hecker
P304
P356
10.2337/DIACARE.29.02.06.DC05-0724
P407
P577
2006-02-01T00:00:00Z